Results 21 to 30 of about 114,065 (338)
Leukaemia Cutis: Clinical Features and Outcomes of 56 Patients
Acta Dermato-Venereologica, 2022 Leukaemia is a malignant neoplasm of the haematopoietic system. Cutaneous manifestations of leukaemia are called leukaemia cutis, and are regarded as a sign of poorer prognosis and shorter survival time.
Hwa Jung Yook +8 more
doaj +1 more source
The Lancet Oncology, 2022 BACKGROUND Targeted time-limited treatment options are needed for patients with relapsed or refractory chronic lymphocytic leukaemia. The aim of this study was to investigate the efficacy of minimal residual disease (MRD)-guided, time-limited ibrutinib ...
A. Kater +21 more
semanticscholar +1 more source
Chronic lymphocytic leukaemia. [PDF]
Anticancer research, 2009 Chronic lymphocytic leukaemia remains the most common adult leukaemia in Western countries. In this review we tried to give an overview of the important prognostic markers and the developments in this field. We also reflected about the accumulative character of the disease and the influence of the micro-environment on the CLL cell.
Jerina, Boelens +3 more
openaire +3 more sources
Annals of Oncology, 2020 B. Eichhorst1, T. Robak2, E. Montserrat3, P. Ghia4, P. Hillmen5, M. Hallek6 & C. Buske7, on behalf of the ESMO Guidelines Committee* Klinik I für Innere Medizin, Universität zu Köln, Köln, Germany; Department of Hematology, Medical University of Lodz ...
B. Eichhorst +11 more
semanticscholar +1 more source
Virchows Archiv, 2022 The International Clinical Advisory Committee reviewed advances in our understanding of the clinicopathologic and biologic features of chronic lymphocytic leukaemia/small lymphocytic lymphoma, B-cell prolymphocytic leukaemia, and mantle cell lymphoma ...
B. Sander, E. Campo, E. Hsi
semanticscholar +1 more source
Polish Journal of Pathology, 2020 The association of small lymphocytic lymphoma/chronic lymphocytic leukaemia (CLL) with different malignancies has been reported in the literature. Also the occurrence of a second haematological disease has been described, more frequently as a secondary ...
Stefano Licci
doaj +1 more source
Another treatment option for relapsed or refractory chronic lymphocytic leukaemia. [PDF]
, 2017 We hereby report the clinical and biologic features of 33 of 4680 (0.7%) patients with chronic lymphocytic leukemia (CLL), managed at 10 Italian centers, who developed Hodgkin lymphoma (HL), a rare variant of Richter syndrome.
Mauro, Francesca Romana
core +1 more source
Chronic Lymphocytic Leukaemia [PDF]
, 2022 AbstractAlthough chronic lymphocytic leukaemia (CLL) was one of the first two entities in which CAR-T cells were evaluated, it has not yet arrived in the clinical routine. Since the landmark study by Porter et al. (2011), only six CLL-specific clinical trials have been published, altogether comprising no more than 155 patients (Porter et al. 2015; Gill
Olivier Tournilhac, Peter Dreger
openaire +1 more source
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine [PDF]
Open Biology, 2020 The transcription factor HIF-1α is overexpressed in chronic lymphocytic leukaemia (CLL), where it promotes leukaemia progression by favouring the interaction of leukaemic cells with protective tissue microenvironments. Here, we tested the hypothesis that
Roberta Valsecchi +7 more
doaj +1 more source
COVID-19-Induced Hyperleucocytosis in Chronic Lymphocytic Leukaemia
European Journal of Case Reports in Internal Medicine, 2021 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for the current global pandemic, coronavirus disease 2019 (COVID-19).
Balraj Singh +5 more
doaj +1 more source